1-5 of 5
Tejaswini Dhawale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pilot Randomized Controlled Trial of an Educational Video for Chimeric Antigen Receptor (CAR)-T Cell Therapy Recipients

Patrick Connor Johnson, Tejaswini Dhawale, Richard Newcomb, Anna Barata, Kyle Karpinski, Mitchell Lavoie, Dagny Vaughn, Kathleen Hennessey, David Scheider, Hermioni L Amonoo, Angelo Volandes, Areej El-Jawahri
Journal: Blood
Blood (2023) 142 (Supplement 1): 255.
https://doi.org/10.1182/blood-2023-172776
Published: 2023
Journal Articles

Longitudinal Patient-Reported Outcomes in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy

Patrick Connor Johnson, Tejaswini Dhawale, Mitchell W. Lavoie, Kyle Karpinski, Netana H. Markovitz, Kathleen Hennessey, Matthew Frigault, Areej El-Jawahri
Journal: Blood
Blood (2022) 140 (Supplement 1): 5232–5233.
https://doi.org/10.1182/blood-2022-163194
Published: 2022
Journal Articles

Perception of Prognosis, Quality of Life, and Distress in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy

Tejaswini Dhawale, P. Connor Johnson, Mahmoud R. Gaballa, Ashley Nelson, Mitchell W. Lavoie, Matthew Frigault, Kofi Boateng, Claire Greydanus, Areej El-Jawahri
Journal: Blood
Blood (2022) 140 (Supplement 1): 10989–10990.
https://doi.org/10.1182/blood-2022-162494
Published: 2022
Journal Articles

The Associations between Coping Strategy Use and Patient-Reported Outcomes in Patients with Acute Myeloid Leukemia

Matthew J. Reynolds, Monica Bodd, Ashley Nelson, Richard Newcomb, P. Connor Johnson, Tejaswini Dhawale, Lauren Heuer, Sabah Gillani, Daniel Yang, Emma C. Deary, Elizabeth Daskalakis, Lauren Goldschen, Andrew M. Brunner, Amir T. Fathi, Thomas W. LeBlanc, Areej El-Jawahri, Hermioni L. Amonoo
Journal: Blood
Blood (2021) 138 (Supplement 1): 4131.
https://doi.org/10.1182/blood-2021-151895
Published: 2021
Journal Articles

Comparison of Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T-Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL

Jordan Gauthier, MD, Alexandre V. Hirayama, MD, Kevin A. Hay, MDFRCPC,MSc, Daniel Li, PhD, James Lymp, PhD, Alyssa Sheih, PhD, Janaki Purushe, PhD, Barbara S. Pender, MSc, Reed M. Hawkins, BS, Aesha Vakil, MSc, Tinh-Doan Phi, BS, Rachel N. Steinmetz, BS, Aude G. Chapuis, MD, Brian G. Till, MD, Tejaswini Dhawale, MD, Paul C. Hendrie, MD PhD, Hans-Peter Kiem, MD PhD, Jorge Ramos, DO, Mazyar Shadman, Ryan D. Cassaday, MD, Utkarsh H. Acharya, DO, Stanley R. Riddell, MD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 299.
https://doi.org/10.1182/blood-2018-99-111061
Published: 2018